Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Accelmed

Investor type Venture Capital
Founders Uri Geiger

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 41
Average round size
info
The average size of a deal this fund participated in
$22M
Portfolio companies 24
Rounds per year 3.15
Lead investments 10
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.41
Exits 8
Key employees 4
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Medical Device
  • Biotechnology
  • Medical
  • Hospital
Summary

The company was established in Asia in Israel. The main department of described VC is located in the Tel Aviv.

Among the most popular fund investment industries, there are Health Care, Health Diagnostics. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight EndoGastric Solutions, CartiHeal, Corvia Medical. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Israel.

The overall number of key employees were 4.

Opposing the other organizations, this Accelmed works on 2 percentage points less the average amount of lead investments. The fund is generally included in 2-6 deals every year. The high activity for fund was in 2015. Despite it in 2019 the fund had an activity. Considering the real fund results, this VC is 35 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top amount of exits for fund were in 2016.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Accelmed, startups are often financed by Elron Electronic Industries, Access Medical Ventures, Third Rock Ventures. The meaningful sponsors for the fund in investment in the same round are Elron Electronic Industries, Access Medical Ventures, Third Rock Ventures. In the next rounds fund is usually obtained by Elron Electronic Industries, Peregrine Ventures, Access Medical Ventures.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Accelmed:
Typical Co-investors
Accelmed is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Accelmed:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

MedMinder Systems

Health Care
Hospital
Medical
$25M30 Aug 2022 Massachusetts, United States

MedMinder Systems

Health Care
Hospital
Medical
$10M24 Aug 2022 Massachusetts, United States

Diagnostic Robotics

Analytics
Artificial Intelligence
Health Care
Hospital
Machine Learning
Robotics
$45M25 Jul 2022 Tel Aviv-Yafo, Tel Aviv District, Israel

Veranex

Health Diagnostics
Information Services
Medical Device
18 May 2022 Raleigh, North Carolina, United States

Click Therapeutics

Biotechnology
Health Care
Information Technology
Medical Device
Other Healthcare Technology Systems
Pharmaceutical
Therapeutics
$52M22 Oct 2021 New York, New York, United States

Keystone Dental

Biopharma
Health Care
Medical Device
$25M01 Sep 2021 Massachusetts, United States

TailorMed

Financial Services
FinTech
Fitness
Health Care
Machine Learning
Wellness
$20M07 Jun 2021 Tel Aviv-Yafo, Tel Aviv District, Israel

Cynerio

Cyber Security
Health Care
Information Technology
Medical Device
Network Security
$30M19 May 2021 New York, New York, United States

Memic Innovative Surgery

Biotechnology
Emergency Medicine
Health Care
Medical Device
Personal Health
Robotics
$96M12 Apr 2021 Israel, Tel Aviv District, Israel
News
Memic Innovative Surgery Raises $96 Million

– Meemic Innovative Surgery raised $96m in a Series D financing round.
– The round was led by Peregrine Ventures and Ceros with participation from OurCrowd and Accelmed.
– Funding will support commercialization of the Hominis® robotic-assisted surgical platform in the U.S. and potentially in other countries around the world as the company also plans to expand marketing and sales efforts outside the U.S.
– The financing will also support continued research and development efforts including expanding the company’s portfolio of products and manufacturing scaleup, as well as provide world-class customer support and training.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Accelmed?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: